CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 58 enrolled
Drug / intervention
Zolpidem +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04102345
NCT04102345Early Ph 1Completed
CompareCT.gov

Lavender vs Zolpidem: Sleep Quality During Diagnostic Polysomnography

HealthPartners Institute·interventional·Posted Sep 25, 2019·Updated Mar 17, 2021

In Brief

A Early Phase 1 clinical trial evaluating Lavender Aromatherapy and Zolpidem for Sleep. Completed, enrolled 58 participants across 1 site.

Detailed Summary

In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedSep 25, 2019
Enrollment StartSep 4, 2019
Primary CompletionNov 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.8 years ago

Interventions

Lavender Aromatherapyother

Commercially available lavender essential oil and diffuser.

Zolpidemdrug

Physician directed, pre-prescribed. Study team does not prescribe zolpidem.